CURE ALZHEIMER'S FUND AWARDS 1,000TH RESEARCH GRANT

Nonprofit Marks Major Milestone in Global Effort to Prevent, Slow and Cure Alzheimer's Disease

WELLESLEY, Mass., Oct. 7, 2025 /PRNewswire/ -- Cure Alzheimer's Fund (CureAlz), a nonprofit organization dedicated to supporting the most promising research aimed at preventing, slowing and ultimately reversing Alzheimer's disease, announced today it has awarded its 1,000th research grant. This milestone underscores the organization's continued commitment to advancing the science that will bring us closer to effective treatments and, ultimately, a cure for Alzheimer's disease.

"From the beginning, our vision was to accelerate the science that could change the course of Alzheimer's," said Henry McCance, Co-Founder and Chair of Cure Alzheimer's Fund. "Awarding our 1,000th grant is not just a milestone, but a result of the unwavering dedication of our scientists, the generosity of our donors and the belief that, together, we can bring hope to millions of families impacted by this devastating disease."

Since its founding in 2004, Cure Alzheimer's Fund has supported some of the most important initiatives in Alzheimer's research, including the Alzheimer's Genome Project™, which uncovered novel genes linked to the disease, and the development of "Alzheimer's in a Dish," a 3-D human cell model that accelerates the testing of potential therapies. CureAlz also has established collaborative consortia focused on such critical areas as tau pathology, the APOE gene, the neuroimmune response, the blood-brain barrier, the role of the microbiome and, most recently, brain aging. Together, these innovative initiatives are reshaping scientific understanding of Alzheimer's and opening new pathways toward next-generation treatments and long-term solutions.

"Awarding our 1,000th grant is both a tremendous accomplishment and a meaningful reminder of why we exist," said Meg Smith, CEO of Cure Alzheimer's Fund. "This milestone celebrates not only the number of grants awarded, but also the scientific rigor behind them—guided by our external scientific leaders, each grant advances the most promising avenues of Alzheimer's research. It is a privilege to champion the extraordinary work of scientists who are driving real progress against this devastating disease. We are inspired by what has been achieved—and remain steadfast in our mission to push forward until Alzheimer's is finally defeated."

About Cure Alzheimer's Fund
Cure Alzheimer's Fund (CureAlz) is a nonprofit dedicated to funding the most promising research to prevent, slow or reverse Alzheimer's disease. Since its founding in 2004, CureAlz has provided $235 million to more than 300 of the world's leading researchers and has achieved a 100% perfect score and a Four-Star rating for 13 consecutive years from Charity Navigator. Our Board of Directors, Trustees and a core group of other donors direct their donations to our overhead expenses so that 100% of general donations go to our research program. For more information, visit CureAlz.org.

MEDIA CONTACT: Barbara Chambers
[email protected], 978-417-9890

SOURCE Alzheimer's Disease Research Foundation